United States · FDA National Drug Code directory
GABAPENTIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-621_bc931d95-28ae-405b-ad93-e1fe0b51eab9
- Product NDC
- 71610-621
- Form
- TABLET
- Composition / generic term
- Gabapentin
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20211001
- Source listing expiry
- 20261231
Source-listed ingredients
- GABAPENTIN — 600 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 15 TABLET in 1 BOTTLE (71610-621-15) · 71610-621-15
- 30 TABLET in 1 BOTTLE (71610-621-30) · 71610-621-30
- 45 TABLET in 1 BOTTLE (71610-621-45) · 71610-621-45
- 60 TABLET in 1 BOTTLE (71610-621-53) · 71610-621-53
- 90 TABLET in 1 BOTTLE (71610-621-60) · 71610-621-60
- 120 TABLET in 1 BOTTLE (71610-621-70) · 71610-621-70
- 135 TABLET in 1 BOTTLE (71610-621-73) · 71610-621-73
- 180 TABLET in 1 BOTTLE (71610-621-80) · 71610-621-80
- 270 TABLET in 1 BOTTLE (71610-621-92) · 71610-621-92
- 360 TABLET in 1 BOTTLE (71610-621-94) · 71610-621-94
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →